Our Medical Clinic in Los Angeles is specializing in Hepatitis C Trials with drugs in development from
Gilead Sciences, Bristol-Myers Squibb, Abbvie, Merck and Idenix Pharmaceuticals.

Painless Fibroscan instead of Liver Biopsy

 

Ruane Medical is the first clinic in Los Angeles to use the FibroScan®502 Touch. The FibroScan®502 Touch is an FDA approved device to study the liver directly for any signs of scarring (cirrhosis) without having to use a needle.

 

The Fibroscan can measure the texture of the liver by using "shear wave" vibration to the liver through a blunt button applied to the chest wall. There are no needles involved. No pain.

 

Results from the FibroScan ® 502 Touch device are accepted by the FDA in clinical trials in place of liver biopsy (organ puncture with a needle).

 

Fibroscan of the liver is not the same as ultrasound of the liver. Ruane Medical welcomes the FibroScan®502 Touch device as a genuine advance in the care of patients with Hepatitis C.

 

 

As seen advertised

Fill out this form to get included in out hepatitis c drug trials database

Contact Ruane Medical for Hepatits C Drug Trials

About Ruane Medical

Liver Scan instead of liver biopsy

Hepatitis C Drug Trials that we offer

FDA regulations and information about drug trials

Video to find out more about our location

How to get to our office by car